The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
Spotlight Series: HIV, the Gut and Digestive Issues
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

U.S. News

More Than 700 People on ADAP Waiting Lists; Program Needs $214 Million in New Funding, Advocates Say

September 5, 2003

At least 700 HIV-positive people in the United States are on waiting lists to receive antiretroviral drugs from AIDS Drug Assistance Programs, and two people have died while waiting for the drugs, the Charleston Gazette reports (Heys, Charleston Gazette, 9/3). The federal-state ADAP program provides free or low-cost medication to low-income HIV-positive individuals who do not qualify for Medicaid or other drug assistance programs. Many state ADAPs are experiencing financial trouble due to high demand for the drugs, soaring prescription costs and state budget shortfalls. Fifteen states currently have waiting lists or access restrictions on their ADAPs, and four more states anticipate having to impose new or additional restrictions on their programs in fiscal year 2003 (Kaiser Daily HIV/AIDS Report, 8/29). Federal funding for ADAP has increased from $52 million in 1996 to $639 million last year, and during that time, the number of people using the programs rose 154% and monthly drug costs increased by 370% (Charleston Gazette, 9/3).

Additional Funding
AIDS policy experts estimate that ADAP will require a total of $214 million in new federal funding next year in order to restore stability and serve the people currently on waiting lists (ADAP Working Group release, 9/2). According to the Gazette, an appropriations bill before the Senate this week would increase ADAP funding by only $25 million. The House version of the bill, which was passed in July, includes about $39 million in new funding (Charleston Gazette, 9/3). According to the ADAP Working Group, an amendment to the Senate bill would fully fund ADAPs. "We ask all Senators from both sides of the aisle to support that amendment, or any modification of it that will fully fund ADAP, because it is unthinkable that in our great nation, individuals are dying while waiting to gain access to vital medications through ADAP," Gene Copello, executive director of Florida AIDS Action and co-chair of the Southern AIDS Coalition, said (ADAP Working Group release, 9/2).

Back to other news for September 5, 2003

Reprinted with permission from You can view the entire Kaiser Daily HIV/AIDS Report, search the archives, or sign up for email delivery at The Kaiser Daily HIV/AIDS Report is published for, a free service of the Kaiser Family Foundation, by The Advisory Board Company. © 2003 by The Advisory Board Company and Kaiser Family Foundation. All rights reserved.

  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily HIV/AIDS Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
See Also
2014 National ADAP Monitoring Project Annual Report (PDF)
ADAP Waiting List Update: 35 People in 1 State as of July 23
More on ADAP Restrictions and Waiting Lists
Find out how a Walgreens specially trained pharmacist can help you